Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)
NCT03093974
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
377
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Cystic Fibrosis Bronchiectasis
Interventions
DRUG:
CMS
OTHER:
Placebo
Sponsor
Zambon SpA